Cargando…

Stereotactic body radiation therapy for stage I medically operable non-small cell lung cancer

Stereotactic ablative body radiation therapy (SBRT) has emerged as the standard treatment for inoperable patients with stage I non-small cell lung cancer (NSCLC). In the current study, we retrospectively analyzed a medically operable patient cohort with stage I NSCLC who refused surgery and subseque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kocak Uzel, Esengul, Bagci Kilic, Melisa, Morcali, Hasan, Uzel, Omer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300007/ https://www.ncbi.nlm.nih.gov/pubmed/37369756 http://dx.doi.org/10.1038/s41598-023-37643-7

Ejemplares similares

Radiotherapy in Lung Cancer: Current and Future Role
por: Uzel, Esengül Koçak, et al.
Publicado: (2019)

Is Single Cord Irradiation Going to Be a New Standard for T1a Glottic Carcinoma?
por: Kocak Uzel, Esengul, et al.
Publicado: (2020)

Recurrent Solitary Fibrous Tumor in Intradural Extramedullary Space: Case Report and Review of the Literature
por: Dincer, Neris, et al.
Publicado: (2021)

Cardiac protective techniques in left breast radiotherapy: rapid selection criteria for routine clinical decision making
por: Kirli Bolukbas, Meltem, et al.
Publicado: (2023)

Malignant Fibrous Histiocytoma of the Breast in Young Male Patient: A Case Report and a Review of the Literature
por: Kocak Uzel, Esengul, et al.
Publicado: (2013)

Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Small Academic Hospital Experience
por: Factor, Oren B., et al.
Publicado: (2014)

Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens
por: Siva, Shankar, et al.
Publicado: (2016)

Hypofractionated stereotactic radiation therapy activates the peripheral immune response in operable stage I non-small-cell lung cancer
por: Zhang, Ting, et al.
Publicado: (2017)

T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer
por: Wu, Lirong, et al.
Publicado: (2021)

Stereotactic body radiation therapy mitigates radiation induced lymphopenia in early stage non-small cell lung cancer
por: McLaughlin, Mark F., et al.
Publicado: (2020)

Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer
por: KIM, MIN-JEONG, et al.
Publicado: (2013)

Reduced Margin Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancers
por: Patel, Mayank, et al.
Publicado: (2020)

Dosimetric and Radiobiological Evaluation of Patient Setup Accuracy in Head-and-neck Radiotherapy Using Daily Computed Tomography-on-rails-based Corrections
por: Jurkovic, Ines-Ana, et al.
Publicado: (2018)

Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer
por: Verma, Vivek, et al.
Publicado: (2016)

Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy
por: Tatekawa, Kotoha, et al.
Publicado: (2014)

Stereotactic body radiation therapy or surgery for stage I–II non-small cell lung cancer treatment?—outcomes of a meta-analysis
por: Zhang, Qiuning, et al.
Publicado: (2019)

Commentary: Stereotactic body radiation therapy versus surgery for stage I non–small cell lung cancer in healthy patients: Not quite there yet
por: Sideris, Antonios, et al.
Publicado: (2022)

Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy
por: Kumar, Sameera S., et al.
Publicado: (2017)

Proton stereotactic body radiation therapy for non-small cell lung cancer
por: Diwanji, Tejan, et al.
Publicado: (2020)

Stereotactic body radiation therapy versus fractionated radiation therapy for early-stage bronchopulmonary carcinoid
por: Wegner, Rodney E, et al.
Publicado: (2019)

Real-World Results of Stereotactic Body Radiotherapy for 399 Medically Operable Patients with Stage I Histology-Proven Non-Small Cell Lung Cancer
por: Onishi, Hiroshi, et al.
Publicado: (2023)

Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC)
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Stereotactic body radiation therapy (SBRT) for patients with stage I non-small cell lung cancer is applicable to more tumors than sublobar resection
por: Song, Andrew J., et al.
Publicado: (2021)

Outcomes and toxicity of stereotactic body radiation therapy for advanced stage ultra‐central non‐small cell lung cancer
por: Cong, Yang, et al.
Publicado: (2019)

A hybrid planning strategy for stereotactic body radiation therapy of early stage non‐small‐cell lung cancer
por: Liu, Han, et al.
Publicado: (2018)

Stereotactic body radiation therapy for early-stage non–small-cell lung cancer in octogenarians and older: an alternative treatment
por: Bei, Yanping, et al.
Publicado: (2020)

Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy Outcomes in a Single Institution
por: Doupnik, Nathan P, et al.
Publicado: (2022)

Definition of stereotactic body radiotherapy: Principles and practice for the treatment of stage I non-small cell lung cancer
por: Guckenberger, M., et al.
Publicado: (2013)

Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers
por: Berg, Janna, et al.
Publicado: (2021)

Differences in rates of radiation-induced true and false rib fractures after stereotactic body radiation therapy for Stage I primary lung cancer
por: Miura, Hideharu, et al.
Publicado: (2015)

Stereotactic Body Radiation Therapy versus Surgical Resection for Stage I/II Hepatocellular Carcinoma
por: Birgin, Emrullah, et al.
Publicado: (2023)

Imaging characteristics of local recurrences after stereotactic body radiation therapy for stage I non-small cell lung cancer: Evaluation of mass-like fibrosis
por: Hayashi, Shinya, et al.
Publicado: (2015)

Anemia is a poor prognostic factor for stage I non-small cell lung cancer (NSCLC) patients treated with Stereotactic Body Radiation Therapy (SBRT)
por: Pathak, Rima S., et al.
Publicado: (2019)

Wedge Resection vs. Stereotactic Body Radiation Therapy for Clinical Stage I Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Peng, Lei, et al.
Publicado: (2022)

Stereotactic body radiation therapy for non-small cell lung cancer: A review
por: Prezzano, Kavitha M, et al.
Publicado: (2019)

Assessing the Need for Adjuvant Chemotherapy After Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Carcinoma
por: Jumeau, Raphaël, et al.
Publicado: (2016)

Symptomatic radiation-induced rib fractures after stereotactic body radiotherapy for early-stage non-small cell lung cancer
por: Kita, Nozomi, et al.
Publicado: (2023)

Stereotactic body radiation therapy for metastatic lung metastases
por: Kimura, Tomoki, et al.
Publicado: (2022)

Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer
por: Shen, Ze-Tian, et al.
Publicado: (2015)

Clinical results of stereotactic body radiotherapy for Stage I small-cell lung cancer: a single institutional experience
por: Shioyama, Yoshiyuki, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8ieah8mk0joq8mcbfullmlrnsn